
Polygenic Risk Score for Reduced EGFR is Associated with Adverse Events in a Chronic Kidney Disease Cohort — The German Chronic Kidney Disease Study
This clinical trial was presented on day 2 of the th ERA Congress 2022 on May 20 2022 by Drs.

This clinical trial was presented on day 2 of the th ERA Congress 2022 on May 20 2022 by Drs.

This clinical trial was presented on day 2 of the ERA Congress 2022 on May 20th 2022 by Drs. Simon

This clinical trial was presented on day 2 of the ERA Congress 2022 on May 20th 2022 by Drs Jonathan

This clinical trial was presented on day 2 of the ERA Congress 2022 on May 20th 2022 by Kim Jasbutis,

This clinical trial was presented on day 2 of the th ERA Congress 2022 on May 20 2022 by Drs.

This clinical trial was presented on day 2 of the ERA Congress 2022 on May 20th 2022 by Drs. Line

This clinical trial was presented on day 2 of the ERA Congress 2022 on May 20th 2022 by Prof. Ronald

This clinical trial was presented on day 2 of the ERA Congress 2022 on May 20th 2022 by Drs. Johannes

This paper was presented on day 1 of the ERA th Congress 2022 on May 19 2022 by Drs. Mónica

This paper was presented on day 1 of the ERA Congress 2022 on May 19th 2022 by Drs. Francisco-Jose Borrego-Utiel,